As we and others have previously identified soluble fractalkine to belong to the endothelial inflammation signature of SSc (17, 21), we investigated whether the expression of the CX3CR1 fractalkine receptor in cytotoxic immune cells could be affected in the context of enhanced release of this chemokine. This evidence concerns the gene CX3CR1 and systemic sclerosis.